Success Story: NIW Approved under Premium Processing for a Clinical Research Physician Advancing Heart Failure and Cancer Mechanism Studies

Posted by wegreened on April 16, 2026 in NIW, General Medicine (Public Health, Clinical Research, Infectious Diseases, Vaccines, Virology, Epidemiology, Clinical Psychology, Psychiatry)

Client’s Testimonial:

"Thank you so much! I truly appreciate your work and guidance in this process."

On February 3^rd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Associate in the Field of Clinical Research (Approval Notice).

General Field: Clinical Research

Position at the Time of Case Filing: Research Associate

Country of Origin: Mexico

State of Residence at the Time of Filing: Georgia

Approval Notice Date: February 3^rd, 2025

Processing Time: 2 months, 5 days (Premium Processing Requested)

Case Summary:

An EB-2 NIW petition, filed with Premium Processing from the outset, was approved for the client, a physician and clinical research specialist whose work addresses a high-impact intersection in medicine: understanding how heart failure can promote cancer development, and translating those mechanisms into targeted preventatives and therapies.

Research Leadership and National Impact

The client holds an M.D. and is currently employed as a research associate at a U.S.-based cancer research center. As an expert in clinical research, the client’s proposed endeavor is to continue elucidating the underlying mechanisms through which heart failure promotes cancer development in order to enable the design of novel targeted therapies and preventatives for oncologic and cardiac complications.

We framed this endeavor as an area of clear, substantial merit and national importance because it targets two major sources of morbidity and mortality and aims to generate actionable insights that can reduce complications, improve treatment strategies, and lessen long-term healthcare burden. Rather than relying on broad public health claims, the petition emphasized the client’s track record of producing clinically relevant findings across cardiometabolic risk, heart failure comorbidities, and technology-enabled care delivery, establishing credibility for advancing the proposed heart failure and cancer mechanism work.

The client’s scholarly record reflects consistent productivity and measurable uptake:

6 peer-reviewed journal articles (1 first-authored), 34 abstracts (5 first-authored), and 1 book chapter
54 citations to the client’s published body of work, indicating independent reliance by other researchers
One publication ranking among the top 20% most cited in Clinical Medicine for its year of publication, providing field- and year-normalized context for influence
Research support connected to a major funding source, including the Distance Learning and Telemedicine Grants Program

We did not present these metrics as self-evidently sufficient. Instead, we explained how an adjudicator can interpret them as objective indicators of influence when tied to a coherent clinical research portfolio. The citation record was positioned as evidence that independent teams have used the client’s findings to inform and validate subsequent investigations, and the field-normalized percentile performance helped translate impact beyond raw totals. By focusing on publications, citations, and documented research support, we established robust third-party indicators of the client's standing.

Expert Endorsements

To strengthen the NIW filing, our firm included 2 expert recommendation letters. These letters supported the petition by explaining the client’s clinical research contributions in clear, field-facing terms and by reinforcing why continued work on heart failure and cancer mechanisms can produce meaningful benefits in the United States. One expert noted:

“When this is taken into consideration with her impressive history of publication in the field’s most influential journals, it is clear that [Client’s] work is of great value to her discipline and that she is an irreplaceable presence in the research sphere.”

NIW Approval and Outlook

The NIW approval reflects USCIS’s recognition that the client’s proposed endeavor has substantial merit and national importance, and that the client is well-positioned to advance it through a record of peer-reviewed research, independent reliance reflected in citations, and credible research support. We are honored to have supported the client throughout the process and look forward to the client’s continued contributions toward mechanism-driven strategies that can improve outcomes for patients facing both cardiac and oncologic risks.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%